DYN

Douglas Kerr

Known title: Chief Medical OfficerCIK: 0001814189

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 10, 2026

Dyne Therapeutics highlighted in recent healthcare stock coverage. Dyne Therapeutics appeared in a Benzinga pre‑market roundup of 12 health‑care stocks. Yahoo highlighted the company in a piece about why it is back in the spotlight, and Raymond James analysts listed it among four health‑care stocks they back. The coverage brings renewed attention to DYN as it trades near its recent support level.

this person other insiders at DYN

Transaction History

DYN▼ Sell$24K
DYN▼ Sell$91K
DYN▼ Sell$41K
DYN▼ Sell$16K
DYN▼ Sell$29K
DYN▼ Sell$13K
DYN▲ Buy$0
DYN▼ Sell$18K
DYN▼ Sell$12K
DYN▼ Sell$47K
DYN▼ Sell$18K
DYN▼ Sell$16K
DYN▲ Buy$0
DYN▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.